These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16010797)

  • 1. Hope on the horizon for stroke patients.
    Cornell DH
    N J Med; 1998 Apr; 95(4):61-3. PubMed ID: 16010797
    [No Abstract]   [Full Text] [Related]  

  • 2. Tissue plasminogen activator approved for stroke.
    Barber A; Gommans J
    N Z Med J; 2005 May; 118(1214):U1432. PubMed ID: 15886728
    [No Abstract]   [Full Text] [Related]  

  • 3. Can the therapeutic window for tissue plasminogen activator be extended to 6 hours after stroke onset?
    Alexandrov AV
    Nat Clin Pract Cardiovasc Med; 2005 Jul; 2(7):342-3. PubMed ID: 16265558
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of tissue plasminogen activator to treat acute ischemic stroke.
    Alexandrov AW
    Crit Care Nurse; 2010 Oct; 30(5):77-8. PubMed ID: 20889516
    [No Abstract]   [Full Text] [Related]  

  • 5. Review of tissue plasminogen activator, ischemic stroke, and potential legal issues.
    Liang BA; Lew R; Zivin JA
    Arch Neurol; 2008 Nov; 65(11):1429-33. PubMed ID: 19001160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergency physician survey: recombinant tissue plasminogen activator for stroke.
    Walsh M; Fromm G
    Ann Emerg Med; 2006 Mar; 47(3):297. PubMed ID: 16492504
    [No Abstract]   [Full Text] [Related]  

  • 7. Litigation regarding tPA and stroke.
    Pilcher CA
    Ann Emerg Med; 2009 Mar; 53(3):404; author reply 404-5. PubMed ID: 19231673
    [No Abstract]   [Full Text] [Related]  

  • 8. Tissue plasminogen activator use in a patient with acute ischemic stroke coexisting with meningioma.
    Hsieh HC; Chen CH
    Clin Neurol Neurosurg; 2009 Jul; 111(6):562-3. PubMed ID: 19200644
    [No Abstract]   [Full Text] [Related]  

  • 9. Emergency physician survey: recombinant tissue plasminogen activator for stroke.
    Mann J
    Ann Emerg Med; 2006 Oct; 48(4):476; author reply 477. PubMed ID: 16997689
    [No Abstract]   [Full Text] [Related]  

  • 10. Rapid EEG changes indicate reperfusion after tissue plasminogen activator injection in acute ischaemic stroke.
    Finnigan SP; Rose SE; Chalk JB
    Clin Neurophysiol; 2006 Oct; 117(10):2338-9. PubMed ID: 16926108
    [No Abstract]   [Full Text] [Related]  

  • 11. Using tPA for acute stroke in a rural setting.
    Gross H; Hall C; Switzer JA; Adams RJ; Wang S; Hess DC; Nichols FT; Pardue C
    Neurology; 2007 May; 68(22):1957-8; author reply 1958. PubMed ID: 17536059
    [No Abstract]   [Full Text] [Related]  

  • 12. Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience.
    National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group
    Ann Emerg Med; 2005 Sep; 46(3):243-52. PubMed ID: 16126134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new wave in stroke treatment.
    Harv Heart Lett; 2005 Feb; 15(6):6. PubMed ID: 15772997
    [No Abstract]   [Full Text] [Related]  

  • 14. Dilemmas in geriatrics: scenario 7 results.
    WMJ; 2003; 102(1):55. PubMed ID: 12679973
    [No Abstract]   [Full Text] [Related]  

  • 15. Estimation of Iranian stroke patients eligible for intravenous thrombolysis with tPA.
    Ghandehari K; Zahed AP; Taheri M; Abbasi M; Gorjestani S; Ahmadi AM; Nahayati MA
    Int J Stroke; 2009 Aug; 4(4):236. PubMed ID: 19689746
    [No Abstract]   [Full Text] [Related]  

  • 16. Thrombolytics for hyperacute stroke in children.
    Amlie-Lefond C; Fullerton HJ
    Pediatr Hematol Oncol; 2009; 26(3):103-7. PubMed ID: 19382031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Old drugs, new tricks: update on stroke therapeutics.
    Fagan SC
    Rev Neurol Dis; 2010; 7 Suppl 1():S1-2; quiz S23. PubMed ID: 20410865
    [No Abstract]   [Full Text] [Related]  

  • 18. Alteplase for stroke. Patients and doctors are being misled by promotional pressures.
    Li J; Nathanson LA; Mills TJ; Netland KE; Paula R; Ragland D
    BMJ; 2002 Jun; 324(7353):1581; author reply 1581. PubMed ID: 12092605
    [No Abstract]   [Full Text] [Related]  

  • 19. Response to "A graphic reanalysis of the NINDS Trial".
    Dewey HM; Churilov L; Blacker D; Bladin C; Davis SM; Donnan GA; Gates P; Gerraty RP; Hand P; Levi C; Lindley RI; Markus R; Read S
    Ann Emerg Med; 2010 Feb; 55(2):227-9; author reply 229. PubMed ID: 20116035
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of acute ischemic apoplexy].
    Andersen G; Krieger DW; Iversen HK
    Ugeskr Laeger; 2009 Mar; 171(13):1094. PubMed ID: 19321089
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.